Items
Displaying 1092901-1092950 of 1299881 results.
| Cat.No. | Description | Unit Of Measure |
|---|---|---|
| 45-Y0002045-EA | Typhaneoside | EA |
| 45-Y0002046-EA | Griseofulvin for LC assay and | EA |
| 45-Y0002049-EA | Terpin monohydrate | EA |
| 45-Y0002050-EA | Betacarotene | EA |
| 45-Y0002051-EA | Simvastatin impurity K | EA |
| 45-Y0002053-EA | Achyranthes bidentata root dry | EA |
| 45-Y0002054-EA | Beta-Ecdysterone | EA |
| 45-Y0002056-Y0002056-EA | Tetrahydropalmatine | EA |
| 45-Y0002057-EA | CORYDALIS RHIZOME DRY EXTRACT | EA |
| 45-Y0002058-EA | Fingolimod for system suitability | EA |
| 45-Y0002059-EA | Atazanavir sulfate | EA |
| 45-Y0002060-EA | BOLDINE FOR SYSTEM SUITABILITY | EA |
| 45-Y0002061-EA | Everolimus for system suitability | EA |
| 45-Y0002062-EA | AMOROLFINE FOR PEAK IDENTIFICATION | EA |
| 45-Y0002063-EA | Everolimus for impurity C identification | EA |
| 45-Y0002065-EA | LACOSAMIDE IMPURITY D EUROPEAN | EA |
| 45-Y0002066-EA | PYRIMETHAMINE IMPURITY B EUROPEAN | EA |
| 45-Y0002067-EA | Alfentanil hydrochloride hydrate | EA |
| 45-Y0002068-EA | Typhae pollen dry extract for | EA |
| 45-Y0002069-EA | Simvastatin | EA |
| 45-Y0002071-EA | Calcium folinate for system suitability | EA |
| 45-Y0002073-EA | Betacarotene for system suitability | EA |
| 45-Y0002074-EA | [DEA ITEM], Amfetamine sulfate | EA |
| 45-Y0002076-EA | Asparagine impurity C | EA |
| 45-Y0002077-EA | Discontinued | EA |
| 45-Y0002078-EA | Moxifloxacin for system suitability | EA |
| 45-Y0002079-EA | Mebeverine hydrochloride | EA |
| 45-Y0002080-EA | VANCOMYCIN FOR SYSTEM SUITABILITY | EA |
| 45-Y0002082-EA | Prochlorperazine for system suitability | EA |
| 45-Y0002083-EA | Methyl salicylate | EA |
| 45-Y0002084-EA | Levofloxacin impurity F | EA |
| 45-Y0002085-EA | Levofloxacin hemihydrate | EA |
| 45-Y0002087-EA | Loperamide for system suitability | EA |
| 45-Y0002088-EA | Chlorprothixene for system suitability | EA |
| 45-Y0002089-EA | Levofloxacin for system suitability | EA |
| 45-Y0002090-EA | Regorafenib monohydrate | EA |
| 45-Y0002092-EA | REGORAFENIB IMPURITY D EUROPEAN | EA |
| 45-Y0002093-EA | Regorafenib impurity A | EA |
| 45-Y0002094-EA | Flupentixol for system suitability | EA |
| 45-Y0002095-EA | PRAZOSIN IMPURITY A EUROPEAN PHARMACOPO | EA |
| 45-Y0002096-EA | Ginsenoside Rg1 | EA |
| 45-Y0002097-EA | Nilotinib hydrochloride monohydrate | EA |
| 45-Y0002100-EA | Nilotinib for system suitability | EA |
| 45-Y0002101-EA | Pantothenate for peak identification | EA |
| 45-Y0002102-EA | Fenoterol for system suitability, | EA |
| 45-Y0002103-EA | NILOTINIB IMPURITY A EUROPEAN | EA |
| 45-Y0002107-EA | MEBEVERINE FOR SYSTEM SUITABILITY | EA |
| 45-Y0002109-EA | Pantolactone | EA |
| 45-Y0002111-EA | NILOTINIB IMPURITY B EUROPEAN | EA |
| 45-Y0002112-EA | DRONEDARONE IMPURITY B EUROPEAN | EA |
